1-10 of 10
Daniel Speiser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3166: The degree of conserved interferon gamma signaling guides response to immune checkpoint blockade therapy

Catherine Grasso, Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Ameya Champhekar, Egmidio Medina, Davis Torrejon, Daniel Shin, Michael Quist, Petra Ross-Mcdonald, Megan Wind-Rotolo, Daniel Speiser, Anusha Kalbasi, Anthony Ribas
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3166.
https://doi.org/10.1158/1538-7445.AM2020-3166
Published: 15 August 2020
View article titled, Abstract 3166: The degree of conserved interferon gamma signaling guides response to immune checkpoint blockade therapy
Journal Articles

Abstract A01: Associations of lymph-angiogenesis with immune profiles of melanoma patients

Natacha Bordry, Philippe Gannon, Periklis Foukas, Igor Letovanec, Christiane Meyer, Amandine Legat, Pu Yan, Emanuela Romano, Melody Swartz, Daniel Speiser
Journal: Cancer Research
Cancer Res (2015) 75 (1_Supplement): A01.
https://doi.org/10.1158/1538-7445.CHTME14-A01
Published: 12 January 2015
View article titled, Abstract A01: Associations of lymph-angiogenesis with immune profiles of melanoma patients
Journal Articles

Abstract #5059: A phase I dose-escalation study with the modified IL-2/anti-DNA immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumors: Preliminary results of safety, pharmacokinetics, immunogenicity, and biological effects

Silke Gillessen, Elisa Gallerani, Joachim Beck, Julien Laurent, Veit Erpenbeck, Daniel Speiser, Arnoud Templeton, Ulrike Gnad-Vogt, Cristiana Sessa, Roger Stupp
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5059.
Published: 01 May 2009
View article titled, Abstract #5059: A phase I dose-escalation study with the modified IL-2/anti-DNA immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumors: Preliminary results of safety, pharmacokinetics, immunogenicity, and biological effects
Journal Articles

Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance

Alfred Zippelius, Pascal Batard, Verena Rubio-Godoy, Gilles Bioley, Danielle Liénard, Ferdy Lejeune, Donata Rimoldi, Philippe Guillaume, Norbert Meidenbauer, Andreas Mackensen, Nathalie Rufer, Norbert Lubenow, Daniel Speiser, Jean-Charles Cerottini, Pedro Romero, Mikaël J. Pittet
Journal: Cancer Research
Cancer Res (2004) 64 (8): 2865–2873.
https://doi.org/10.1158/0008-5472.CAN-03-3066
Published: 15 April 2004
View article titled, Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance
Open the PDF for Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance in another window
Journal Articles

Distinct classes of CpG oligonucleotides differentially enhance human Melan A- and influenza matrix-peptide specific CD8+ T cell responses in vitro.

Gunther Hartmann, Simon Rothenfusser, Veit Hornung, Daniel Speiser, Stefan Endres
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 501.
Published: 01 April 2004
View article titled, Distinct classes of CpG oligonucleotides differentially enhance human Melan A- and influenza matrix-peptide specific CD8+ T cell responses in vitro.
Journal Articles

Lack of BRAF Mutations in Uveal Melanoma

Donata Rimoldi, Suzanne Salvi, Danielle Liénard, Ferdy J. Lejeune, Daniel Speiser, Leonidas Zografos, Jean-Charles Cerottini
Journal: Cancer Research
Cancer Res (2003) 63 (18): 5712–5715.
Published: 01 October 2003
View article titled, Lack of BRAF Mutations in Uveal Melanoma
Open the PDF for Lack of BRAF Mutations in Uveal Melanoma in another window
Journal Articles

Tumor-reactive, SSX-2-specific CD8+ T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients

Maha Ayyoub, Donata Rimoldi, Philippe Guillaume, Pedro Romero, Jean-Charles Cerottini, Danila Valmori, Daniel Speiser
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5601–5606.
Published: 18 September 2003
View article titled, Tumor-reactive, SSX-2-specific CD8<sup>+</sup> T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients
Open the PDF for Tumor-reactive, SSX-2-specific CD8<sup>+</sup> T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients in another window
Journal Articles

Heterogeneous T-Cell Response to MAGE-A10254–262: High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity

Valérie Dutoit, Verena Rubio-Godoy, Pierre-Yves Dietrich, Anne-Lise Quiqueres, Valérie Schnuriger, Donata Rimoldi, Danielle Liénard, Daniel Speiser, Philippe Guillaume, Pascal Batard, Jean-Charles Cerottini, Pedro Romero, Danila Valmori
Journal: Cancer Research
Cancer Res (2001) 61 (15): 5850–5856.
Published: 01 August 2001
View article titled, Heterogeneous T-Cell Response to MAGE-A10<sub>254–262</sub>: <subtitle>High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity</subtitle>
Open the PDF for Heterogeneous T-Cell Response to MAGE-A10<sub>254–262</sub>: <subtitle>High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity</subtitle> in another window
Journal Articles

Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8+ T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients

Danila Valmori, Valérie Dutoit, Danielle Liénard, Donata Rimoldi, Mikaël J. Pittet, Patrick Champagne, Kim Ellefsen, Ugur Sahin, Daniel Speiser, Ferdy Lejeune, Jean-Charles Cerottini, Pedro Romero
Journal: Cancer Research
Cancer Res (2000) 60 (16): 4499–4506.
Published: 01 August 2000
View article titled, Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8<sup>+</sup> T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients
Open the PDF for Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8<sup>+</sup> T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients in another window
Journal Articles

Analysis of the Cytolytic T Lymphocyte Response of Melanoma Patients to the Naturally HLA-A*0201-associated Tyrosinase Peptide 368–376

Danila Valmori, Mikaël J. Pittet, Cedric Vonarbourg, Donata Rimoldi, Danielle Liénard, Daniel Speiser, Rod Dunbar, Vincenzo Cerundolo, Jean-Charles Cerottini, Pedro Romero
Journal: Cancer Research
Cancer Res (1999) 59 (16): 4050–4055.
Published: 15 August 1999
View article titled, Analysis of the Cytolytic T Lymphocyte Response of Melanoma Patients to the Naturally HLA-A*0201-associated Tyrosinase Peptide 368–376
Open the PDF for Analysis of the Cytolytic T Lymphocyte Response of Melanoma Patients to the Naturally HLA-A*0201-associated Tyrosinase Peptide 368–376 in another window